Kacey Anderson, PhD, is Director of Clinical Pharmacology at Terns Pharmaceuticals. Prior to Terns, Dr. Anderson was a Director of Clinical Pharmacology at EQRx International and prior to that she was at Gilead Sciences in clinical pharmacology. Dr. Anderson has worked on programs from early stage (IND filing and development plan) through approval, including being primary author on multiple m2.7.2’s in both US and ex-US submissions in inflammation and oncology disease areas. She has more than eight years of industry experience which includes designing and leading a variety of Phase 1 studies as well as supporting Phase 2 and Phase 3 studies. Dr. Anderson earned her PhD in Pharmaceutical Sciences from the University of Pittsburgh and holds a Bachelor of Science in Chemistry from St. Lawrence University. She is a Fellow of the American College of Clinical Pharmacology (ACCP) and has served on numerous committees and initiatives within ACCP. 

Navin Goyal is a Senior Director and Therapy Area Lead in the Clinical Pharmacology and Pharmacometrics (CPP) Group at Janssen Pharmaceuticals, New Jersey. Dr. Goyal joined ACCP as a student in 2007, has been a Fellow since 2016, currently serves on the Board of Regents and is Treasurer for ACCP. He was the 2021 ACCP Annual Meeting Co-Chair. He has also chaired scientific symposia and presented at previous Annual Meetings.
Dr. Goyal graduated from the Department of Pharmaceutics in College of Pharmacy at University of Florida, Gainesville. After graduation, he worked in the Clinical Pharmacology, Modeling and Simulation group at GSK. At Janssen, Dr. Goyal is the CPP head of cardiovascular, metabolism, retinal, pulmonary hypertension and neuroscience therapy areas. In this role, he is responsible for applying quantitative clinical pharmacology principles and approaches across all phases of drug development spanning from early clinical studies through registration. He has published his research in clinical pharmacology and pharmacometrics across multiple therapy areas including respiratory, CNS, cardiovascular and infectious diseases. Apart from his day job, Dr. Goyal continues to mentor student interns, post-doctoral fellows and scientists within his group at Janssen and through external collaborations.

Zaid Temrikar works as a clinical pharmacologist at Gilead Sciences supporting early and late stage assets within Immunology and Oncology portfolio in Foster City, CA. He completed his PhD from UTHSC in Memphis TN working on PK/PD of anti-infectives. He has held many leadership positions such as part of inaugural ACCP leadership cohort, student president of ISoP and president of AAPS student chapter. He has also been a part of ACCP STEP and ACCP Annual Meeting Program Committee.